Advancing drug development for airway diseases beyond the established mechanisms and symptomatic therapies requires redefining the classifications of airway diseases, considering systemic manifestations, developing new tools and encouraging collaborations.
- Stephen Holgate
- Alvar Agusti
- Theodore F. Reiss